Qualitative characterizations of misinformed disclosure reactions to medications for opioid use disorders and their consequences.

ABSTRACT:

Introduction

Methadone and buprenorphine/naloxone medications are among the most effective treatment options for opioid use disorders, yet many people remain misinformed about their benefits and hold negative perceptions about the use of medications to treat opioid use disorders. Such perceptions, especially negative perceptions based on misinformation, may be especially harmful or stigmatizing within the context of disclosure (i.e., telling another about one's opioid use disorder history or treatment), inhibiting important recovery outcomes and sources of social support.

Methods

Therefore, using the Disclosure Process Model as a framework, the current study seeks to characterize and compare participants' perceptions of stigmatizing reactions to their disclosures of MOUD use

SUBMITTER: Brousseau NM 

PROVIDER: S-EPMC9394166 | biostudies-literature | 2022 Jan

REPOSITORIES: biostudies-literature